Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Expert Review of Vaccines|December 1, 2009
Inactivated and subunit vaccines to prevent shigellosisRobert W Kaminski, Edwin V OaksVaccine|February 16, 2008
Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2aK Ross Turbyfill, Robert W Kaminski, Edwin V OaksInfection and Immunity|April 20, 2006
Mucosal adjuvant properties of the Shigella invasin complexRobert W Kaminski, K Ross Turbyfill, Edwin V OaksJournal of Immunological Methods|April 16, 2013
Multiplexed immunoassay to assess Shigella-specific antibody responsesRobert W Kaminski, Kristen Clarkson, Alexis A Kordis, et al.Journal of Visualized Experiments : Jove|March 19, 2019
A High-throughput Shigella-specific Bactericidal AssayHailey P Weerts, Jigui Yu, Robert W Kaminski, et al.Vaccines|April 23, 2022
From Concept to Clinical Product: A Brief History of the Novel <i>Shigella</i> Invaplex Vaccine's Refinement and EvolutionK Ross Turbyfill, Kristen A Clarkson, Edwin V Oaks, et al.Clinical and Vaccine Immunology : CVI|February 20, 2009
Mucosal adjuvanticity of a Shigella invasin complex with dna-based vaccinesRobert W Kaminski, K Ross Turbyfill, C Chao, et al.Msphere|March 31, 2018
Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of <i>Shigella</i> Artificial InvaplexK Ross Turbyfill, Kristen A Clarkson, Anthony R Vortherms, et al.Infection and Immunity|October 5, 2023
A broadly immunogenic polyvalent <i>Shigella</i> multiepitope fusion antigen protein protects against <i>Shigella sonnei</i> and <i>Shigella flexneri</i> lethal pulmonary challenges in miceSiqi Li, Shaghayegh Anvari, Galen Ptacek, et al.Clinical and Vaccine Immunology : CVI|June 10, 2016
Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine ProductionJisheng Lin, Mark A Smith, William H Benjamin, et al.Pageof 5